Chesapeake Keeps Cashing In

Recs

5

Disney Buys Marvel!

...And David Gardner called it. He's up 1,334%! See what David's recommending that you buy NEXT!

Click here now to find out!

When my Foolish colleague David Lee Smith characterized one of BP's (NYSE: BP) recent acquisitions as following in Chesapeake Energy's (NYSE: CHK) footsteps, he couldn't have been more prescient.

Just weeks later, the two firms have inked yet another major agreement. This time, the international oil and gas major is picking up 25% of Chesapeake's Fayetteville Shale assets for $1.9 billion.

BP isn't the only company to jump on board this Arkansas shale sizzler in the past year. XTO Energy (NYSE: XTO) has been a big buyer, while Petrohawk (NYSE: HK) paid a pretty penny for some prospective acreage, too. BP's payment of around $14,000 an acre actually comes in right around Petrohawk's purchase price.

Before all the Haynesville hoopla, the Fayetteville was looking like the jewel in Chesapeake's crown. Despite its recent overshadowing, this is still a terrific asset. Chesapeake notes that initial production rates are on the rise, while drilling costs are declining. So why is Chesapeake selling?

This deal is part of the same asset monetization program that spurred the company to sell off the Woodford to BP, and to divest a 20% stake in the Haynesville to Plains Exploration & Production (NYSE: PXP). Not only are the joint venture-style deals bringing in cash up front, but the new partners are footing all near-term development costs. This allows Chesapeake to maintain a furious pace of drilling without issuing more debt or equity.

Chesapeake is also actively negotiating a similar venture up in the Marcellus Shale. Any progress on that front with a company like ConocoPhillips (NYSE: COP) or ExxonMobil (NYSE: XOM) would reinforce the majors' apparent appetite for onshore natural gas assets. It should also reassure energy investors that such assets are getting more attractive to potential buyers as prices fall -- not less so.

Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.

Chesapeake Energy is an Inside Value selection. See what other deep values the team has unearthed with a free 30-day trial.

Fool contributor Toby Shute doesn't have a position in any company mentioned. The Motley Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 718846, ~/Articles/ArticleHandler.aspx, 11/8/2009 12:55:00 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Which Companies Can Buy It Like Buffett?

Related Tickers

11/6/2009 4:00 PM
BP $58.43 Down -0.10 -0.17%
BP plc (ADR) CAPS Rating: *****
XOM $72.58 Up +0.08 +0.11%
ExxonMobil Corp CAPS Rating: ****
COP $52.11 Up +0.16 +0.31%
ConocoPhillips CAPS Rating: *****
XTO $43.25 Up +0.07 +0.16%
XTO Energy, Inc. CAPS Rating: *****
HK $23.51 Down -1.01 -4.12%
Petrohawk Energy C… CAPS Rating: ****
PXP $27.75 Up +0.23 +0.84%
Plains Exploration… CAPS Rating: ****
CHK $24.22 Down -0.60 -2.42%
Chesapeake Energy… CAPS Rating: *****

Community: Investing Wiki

Term Of The Hour

PDUFA: The Prescription Drug User Fee Act (PDUFA) is a law enacted by Congress that gives powers to the FDA.

Want to learn more or edit this definition?
Click here to read more!